Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Fermand

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
La Revue Du Praticien|December 1, 1991
[Treatment of myeloma and and expected prognostic progress]J P Fermand
La Revue Du Praticien|February 1, 1994
[Immunoglobulins. Structure, monoclonal or polyclonal characteristics, genetic bases and function]C Schmitt, J P Fermand
La Revue Du Praticien|February 1, 1993
[Benign monoclonal gammopathies]J Sibilia, J P Fermand
Pathologie-Biologie|April 8, 1999
The role of autologous stem cell transplantation in the management of multiple myelomaJ P Fermand, S Brechignac
Presse Medicale (Paris, France : 1983)|April 5, 1997
[Treatment of myeloma: role of intensive treatments]J P Fermand, P Ravaud
Revue Du Rhumatisme (Ed. Francaise : 1993)|April 1, 1993
[High-dose chemotherapy and bone marrow graft in multiple myeloma: hopes and limits]P Ravaud, J P Fermand
Annual Review of Medicine|January 1, 1995
Marrow transplantation for myelomaJ P Fermand, J C Brouet
Hematology/Oncology Clinics of North America|January 8, 2000
Heavy-chain diseasesJ P Fermand, J C Brouet
British Journal of Haematology|February 1, 1994
Interleukin-6 serum levels in patients with multiple myelomaC Emile, J P Fermand, F Danon
European Journal of Immunology|November 1, 1990
Differential effects of low and high concentrations of interleukin 6 on human B cellsY Levy, J P Fermand, J C Brouet
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
La Revue Du Praticien|December 1, 1991
[Treatment of myeloma and and expected prognostic progress]J P Fermand
La Revue Du Praticien|February 1, 1994
[Immunoglobulins. Structure, monoclonal or polyclonal characteristics, genetic bases and function]C Schmitt, J P Fermand
La Revue Du Praticien|February 1, 1993
[Benign monoclonal gammopathies]J Sibilia, J P Fermand
Pathologie-Biologie|April 8, 1999
The role of autologous stem cell transplantation in the management of multiple myelomaJ P Fermand, S Brechignac
Presse Medicale (Paris, France : 1983)|April 5, 1997
[Treatment of myeloma: role of intensive treatments]J P Fermand, P Ravaud
Revue Du Rhumatisme (Ed. Francaise : 1993)|April 1, 1993
[High-dose chemotherapy and bone marrow graft in multiple myeloma: hopes and limits]P Ravaud, J P Fermand
Annual Review of Medicine|January 1, 1995
Marrow transplantation for myelomaJ P Fermand, J C Brouet
Hematology/Oncology Clinics of North America|January 8, 2000
Heavy-chain diseasesJ P Fermand, J C Brouet
British Journal of Haematology|February 1, 1994
Interleukin-6 serum levels in patients with multiple myelomaC Emile, J P Fermand, F Danon
European Journal of Immunology|November 1, 1990
Differential effects of low and high concentrations of interleukin 6 on human B cellsY Levy, J P Fermand, J C Brouet
Pageof 10